MET and prostate carcinoma: One of the earliest and key findings supporting the role of c-Met and HGF in bone metastasis was reported by the Vande Woude group, who demonstrated that prostate cancer bone metastasis patient samples showed significantly increased c-Met protein expression in the metastatic lesions, and also that c-Met expression inversely correlated with androgen receptor expression [29].